Altair-1040-VERSA Laser with built in GDD precompensation and AOM-based power modulation

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is seeking to procure an Altair-1040-VERSA Laser with built-in GDD precompensation and AOM-based power modulation for neural transmission research. The solicitation (Number 75N95025Q00164) requires a variable repetition rate high pulse energy laser with specific technical specifications, including a 1040 nm wavelength, 10 W average power, and pulse duration under 250 fs. Potential vendors must submit electronic responses by 11:00 a.m. Eastern Time on March 26, 2025, and include detailed technical capabilities, pricing information, and their Unique Entity ID from SAM.gov. The evaluation will comprehensively assess technical capability, price, and past performance, with the primary objective of supporting the Neocortex-Cerebellum Circuitry Lab's research into neural communication during animal learning. Vendors must provide a comprehensive technical proposal that demonstrates their ability to meet the laser's intricate specifications.

The solicitation is not designated as a small business set-aside, allowing broader competition among medical and scientific equipment suppliers. The procurement is structured as a firm-fixed price purchase order with a one-year warranty, to be performed at the NIH location in Bethesda, MD 20892. While specific award value details are not explicitly stated, the contract falls under the NAICS category 423450 for Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, and PSC category H165 for Medical, Dental, and Veterinary Equipment Quality Control. The laser will be used in specialized neurological research, indicating a precise and potentially high-value scientific instrument procurement. Vendors should note the competitive nature of the solicitation and the importance of demonstrating technical excellence and competitive pricing to secure the contract.